Phenotypic Assay Development
Phenotypic Assay Development is a methodological framework in drug discovery that establishes a functional, phenotype-based screening system to identify bioactive compounds by measuring observable cellular or organismal responses under defined experimental conditions.
172
Publications
8.8K
Citations
1.3K
Authors
401
Institutions
Publications per year
2017–2026
48
Parents
172
Chemical substructures that enrich for biological activity
Justin Klekota, Frederick P. Roth · Bioinformatics · 2008 · 392 citations · Full text
Assay Guidance Manual [Internet]
Sarine Markossian, A Grossman, Kyle R. Brimacombe et al. · 2004 · 287 citations
1–5 of 172
1.3K
5
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 1.3K
401
Inserm
Paris, France
8 h-index
61 publications
2.5K citations
Harvard University
Cambridge, United States
8 h-index
27 publications
2.5K citations
Université de Lille
Lille, France
6 h-index
60 publications
2.4K citations

Centre National de la Recherche Scientifique
Paris, France
6 h-index
50 publications
2.4K citations
National Institutes of Health
Bethesda, United States
6 h-index
35 publications
4.3K citations
Eli Lilly (United States)
Indianapolis, United States
5 h-index
34 publications
2K citations
University of California, San Francisco
San Francisco, United States
5 h-index
13 publications
1.5K citations
Massachusetts General Hospital
Boston, United States
4 h-index
8 publications
462 citations
1–8 of 401
13 publications · 416 citations
12
h-index
7 publications · 249 citations
7
h-index
AAC · 6 publications · 1K citations
6
h-index
JCM · 5 publications · 181 citations
5
h-index
4 publications · 78 citations
4
h-index
1–5